SAO PAULO — Pharmaceutical company Blau Farmaceutica SA, which listed its shares on Brazil’s B3 stock exchange in April, has opened its first U.S. plasma bank and may consider moving its headquarters and stock listing to the United States. Read More
Brazilian Companies Hear the Siren’s Call of U.S. Stock Exchanges
